Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.690
-0.030 (-1.74%)
At close: Sep 18, 2026, 4:00 PM EDT
1.680
-0.010 (-0.59%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Dogwood Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
57124311443
Market Cap Growth
513.46%3628.17%-70.04%155.97%-89.85%-27.56%
Enterprise Value
4822416-523
Last Close Price
1.694.162.4914.385.90127.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.831.650.052.910.592.94
P/TBV Ratio
1.021.98-2.910.592.94

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.24---
Net Debt / Equity Ratio
-0.14-0.080.01-0.87-0.96-0.97
Net Debt / EBITDA Ratio
0.320.23-0.06---
Quick Ratio
3.392.134.689.256.7410.98
Current Ratio
3.892.765.2111.628.0212.37
Return on Equity (ROE)
-47.77%-49.23%-36.28%-95.14%-112.22%-71.83%
Return on Assets (ROA)
-20.83%-18.95%-15.52%-54.32%-63.75%-41.38%
Return on Capital Employed (ROCE)
-38.00%-32.10%-13.40%-143.10%-168.10%-107.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-62.74%-27.70%-372.30%-47.83%-283.12%-37.46%
Buyback Yield / Dilution
-1355.57%-384.29%-36.84%-69.62%-32.91%-69.06%
SEC Filings: 10-K · 10-Q